Global Epidemic Cerebrospinal Meningitis Vaccines Supply, Demand and Key Producers, 2023-2029
The global Epidemic Cerebrospinal Meningitis Vaccines market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria.
This report studies the global Epidemic Cerebrospinal Meningitis Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Epidemic Cerebrospinal Meningitis Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Epidemic Cerebrospinal Meningitis Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Epidemic Cerebrospinal Meningitis Vaccines total production and demand, 2018-2029, (K Units)
Global Epidemic Cerebrospinal Meningitis Vaccines total production value, 2018-2029, (USD Million)
Global Epidemic Cerebrospinal Meningitis Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Epidemic Cerebrospinal Meningitis Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Epidemic Cerebrospinal Meningitis Vaccines domestic production, consumption, key domestic manufacturers and share
Global Epidemic Cerebrospinal Meningitis Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Epidemic Cerebrospinal Meningitis Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Epidemic Cerebrospinal Meningitis Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Epidemic Cerebrospinal Meningitis Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sanofi Pasteur, GSK, Hulan Bio, Lanzhou Institute of Biological Products, Tianyuan biology, Walvax and Zhifei, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Epidemic Cerebrospinal Meningitis Vaccines market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Epidemic Cerebrospinal Meningitis Vaccines Market, By Region:
1. How big is the global Epidemic Cerebrospinal Meningitis Vaccines market?
2. What is the demand of the global Epidemic Cerebrospinal Meningitis Vaccines market?
3. What is the year over year growth of the global Epidemic Cerebrospinal Meningitis Vaccines market?
4. What is the production and production value of the global Epidemic Cerebrospinal Meningitis Vaccines market?
5. Who are the key producers in the global Epidemic Cerebrospinal Meningitis Vaccines market?
6. What are the growth factors driving the market demand?
Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria.
This report studies the global Epidemic Cerebrospinal Meningitis Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Epidemic Cerebrospinal Meningitis Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Epidemic Cerebrospinal Meningitis Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Epidemic Cerebrospinal Meningitis Vaccines total production and demand, 2018-2029, (K Units)
Global Epidemic Cerebrospinal Meningitis Vaccines total production value, 2018-2029, (USD Million)
Global Epidemic Cerebrospinal Meningitis Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Epidemic Cerebrospinal Meningitis Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Epidemic Cerebrospinal Meningitis Vaccines domestic production, consumption, key domestic manufacturers and share
Global Epidemic Cerebrospinal Meningitis Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Epidemic Cerebrospinal Meningitis Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Epidemic Cerebrospinal Meningitis Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Epidemic Cerebrospinal Meningitis Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sanofi Pasteur, GSK, Hulan Bio, Lanzhou Institute of Biological Products, Tianyuan biology, Walvax and Zhifei, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Epidemic Cerebrospinal Meningitis Vaccines market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Epidemic Cerebrospinal Meningitis Vaccines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Group A and Group C Meningococcal Polysaccharide Vaccine
- Group A and Group C Meningococcal Conjugate Vaccine
- Group ACYW135 Meningococcal Polysaccharide Vaccine
- Group ACYW135 Meningococcal Conjugate Vaccine
- Group A Meningococcal Polysaccharide Vaccine
- Mmeningococcal Group B Vaccine
- Under 1 Year Old
- 1 Year Old and Above
- Pfizer
- Sanofi Pasteur
- GSK
- Hulan Bio
- Lanzhou Institute of Biological Products
- Tianyuan biology
- Walvax
- Zhifei
1. How big is the global Epidemic Cerebrospinal Meningitis Vaccines market?
2. What is the demand of the global Epidemic Cerebrospinal Meningitis Vaccines market?
3. What is the year over year growth of the global Epidemic Cerebrospinal Meningitis Vaccines market?
4. What is the production and production value of the global Epidemic Cerebrospinal Meningitis Vaccines market?
5. Who are the key producers in the global Epidemic Cerebrospinal Meningitis Vaccines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Epidemic Cerebrospinal Meningitis Vaccines Introduction
1.2 World Epidemic Cerebrospinal Meningitis Vaccines Supply & Forecast
1.2.1 World Epidemic Cerebrospinal Meningitis Vaccines Production Value (2018 & 2022 & 2029)
1.2.2 World Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.2.3 World Epidemic Cerebrospinal Meningitis Vaccines Pricing Trends (2018-2029)
1.3 World Epidemic Cerebrospinal Meningitis Vaccines Production by Region (Based on Production Site)
1.3.1 World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Region (2018-2029)
1.3.2 World Epidemic Cerebrospinal Meningitis Vaccines Production by Region (2018-2029)
1.3.3 World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Region (2018-2029)
1.3.4 North America Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.3.5 Europe Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.3.6 China Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.3.7 Japan Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Epidemic Cerebrospinal Meningitis Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Epidemic Cerebrospinal Meningitis Vaccines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Epidemic Cerebrospinal Meningitis Vaccines Demand (2018-2029)
2.2 World Epidemic Cerebrospinal Meningitis Vaccines Consumption by Region
2.2.1 World Epidemic Cerebrospinal Meningitis Vaccines Consumption by Region (2018-2023)
2.2.2 World Epidemic Cerebrospinal Meningitis Vaccines Consumption Forecast by Region (2024-2029)
2.3 United States Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.4 China Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.5 Europe Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.6 Japan Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.7 South Korea Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.8 ASEAN Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.9 India Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
3 WORLD EPIDEMIC CEREBROSPINAL MENINGITIS VACCINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Manufacturer (2018-2023)
3.2 World Epidemic Cerebrospinal Meningitis Vaccines Production by Manufacturer (2018-2023)
3.3 World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Manufacturer (2018-2023)
3.4 Epidemic Cerebrospinal Meningitis Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Epidemic Cerebrospinal Meningitis Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Epidemic Cerebrospinal Meningitis Vaccines in 2022
3.5.3 Global Concentration Ratios (CR8) for Epidemic Cerebrospinal Meningitis Vaccines in 2022
3.6 Epidemic Cerebrospinal Meningitis Vaccines Market: Overall Company Footprint Analysis
3.6.1 Epidemic Cerebrospinal Meningitis Vaccines Market: Region Footprint
3.6.2 Epidemic Cerebrospinal Meningitis Vaccines Market: Company Product Type Footprint
3.6.3 Epidemic Cerebrospinal Meningitis Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Value Comparison
4.1.1 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Comparison
4.2.1 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Consumption Comparison
4.3.1 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value (2018-2023)
4.4.3 United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023)
4.5 China Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers and Market Share
4.5.1 China Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value (2018-2023)
4.5.3 China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023)
4.6 Rest of World Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Epidemic Cerebrospinal Meningitis Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine
5.2.2 Group A and Group C Meningococcal Conjugate Vaccine
5.2.3 Group ACYW135 Meningococcal Polysaccharide Vaccine
5.2.4 Group ACYW135 Meningococcal Conjugate Vaccine
5.2.5 Group A Meningococcal Polysaccharide Vaccine
5.2.6 Mmeningococcal Group B Vaccine
5.3 Market Segment by Type
5.3.1 World Epidemic Cerebrospinal Meningitis Vaccines Production by Type (2018-2029)
5.3.2 World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type (2018-2029)
5.3.3 World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Epidemic Cerebrospinal Meningitis Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Under 1 Year Old
6.2.2 1 Year Old and Above
6.3 Market Segment by Application
6.3.1 World Epidemic Cerebrospinal Meningitis Vaccines Production by Application (2018-2029)
6.3.2 World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application (2018-2029)
6.3.3 World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.1.4 Pfizer Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Details
7.2.2 Sanofi Pasteur Major Business
7.2.3 Sanofi Pasteur Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.2.4 Sanofi Pasteur Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Pasteur Recent Developments/Updates
7.2.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.3.4 GSK Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Hulan Bio
7.4.1 Hulan Bio Details
7.4.2 Hulan Bio Major Business
7.4.3 Hulan Bio Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.4.4 Hulan Bio Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hulan Bio Recent Developments/Updates
7.4.6 Hulan Bio Competitive Strengths & Weaknesses
7.5 Lanzhou Institute of Biological Products
7.5.1 Lanzhou Institute of Biological Products Details
7.5.2 Lanzhou Institute of Biological Products Major Business
7.5.3 Lanzhou Institute of Biological Products Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.5.4 Lanzhou Institute of Biological Products Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7.5.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
7.6 Tianyuan biology
7.6.1 Tianyuan biology Details
7.6.2 Tianyuan biology Major Business
7.6.3 Tianyuan biology Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.6.4 Tianyuan biology Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Tianyuan biology Recent Developments/Updates
7.6.6 Tianyuan biology Competitive Strengths & Weaknesses
7.7 Walvax
7.7.1 Walvax Details
7.7.2 Walvax Major Business
7.7.3 Walvax Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.7.4 Walvax Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Walvax Recent Developments/Updates
7.7.6 Walvax Competitive Strengths & Weaknesses
7.8 Zhifei
7.8.1 Zhifei Details
7.8.2 Zhifei Major Business
7.8.3 Zhifei Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.8.4 Zhifei Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Zhifei Recent Developments/Updates
7.8.6 Zhifei Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Epidemic Cerebrospinal Meningitis Vaccines Industry Chain
8.2 Epidemic Cerebrospinal Meningitis Vaccines Upstream Analysis
8.2.1 Epidemic Cerebrospinal Meningitis Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Epidemic Cerebrospinal Meningitis Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Epidemic Cerebrospinal Meningitis Vaccines Production Mode
8.6 Epidemic Cerebrospinal Meningitis Vaccines Procurement Model
8.7 Epidemic Cerebrospinal Meningitis Vaccines Industry Sales Model and Sales Channels
8.7.1 Epidemic Cerebrospinal Meningitis Vaccines Sales Model
8.7.2 Epidemic Cerebrospinal Meningitis Vaccines Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Epidemic Cerebrospinal Meningitis Vaccines Introduction
1.2 World Epidemic Cerebrospinal Meningitis Vaccines Supply & Forecast
1.2.1 World Epidemic Cerebrospinal Meningitis Vaccines Production Value (2018 & 2022 & 2029)
1.2.2 World Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.2.3 World Epidemic Cerebrospinal Meningitis Vaccines Pricing Trends (2018-2029)
1.3 World Epidemic Cerebrospinal Meningitis Vaccines Production by Region (Based on Production Site)
1.3.1 World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Region (2018-2029)
1.3.2 World Epidemic Cerebrospinal Meningitis Vaccines Production by Region (2018-2029)
1.3.3 World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Region (2018-2029)
1.3.4 North America Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.3.5 Europe Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.3.6 China Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.3.7 Japan Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Epidemic Cerebrospinal Meningitis Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Epidemic Cerebrospinal Meningitis Vaccines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Epidemic Cerebrospinal Meningitis Vaccines Demand (2018-2029)
2.2 World Epidemic Cerebrospinal Meningitis Vaccines Consumption by Region
2.2.1 World Epidemic Cerebrospinal Meningitis Vaccines Consumption by Region (2018-2023)
2.2.2 World Epidemic Cerebrospinal Meningitis Vaccines Consumption Forecast by Region (2024-2029)
2.3 United States Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.4 China Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.5 Europe Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.6 Japan Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.7 South Korea Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.8 ASEAN Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
2.9 India Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029)
3 WORLD EPIDEMIC CEREBROSPINAL MENINGITIS VACCINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Manufacturer (2018-2023)
3.2 World Epidemic Cerebrospinal Meningitis Vaccines Production by Manufacturer (2018-2023)
3.3 World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Manufacturer (2018-2023)
3.4 Epidemic Cerebrospinal Meningitis Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Epidemic Cerebrospinal Meningitis Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Epidemic Cerebrospinal Meningitis Vaccines in 2022
3.5.3 Global Concentration Ratios (CR8) for Epidemic Cerebrospinal Meningitis Vaccines in 2022
3.6 Epidemic Cerebrospinal Meningitis Vaccines Market: Overall Company Footprint Analysis
3.6.1 Epidemic Cerebrospinal Meningitis Vaccines Market: Region Footprint
3.6.2 Epidemic Cerebrospinal Meningitis Vaccines Market: Company Product Type Footprint
3.6.3 Epidemic Cerebrospinal Meningitis Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Value Comparison
4.1.1 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Comparison
4.2.1 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Consumption Comparison
4.3.1 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value (2018-2023)
4.4.3 United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023)
4.5 China Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers and Market Share
4.5.1 China Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value (2018-2023)
4.5.3 China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023)
4.6 Rest of World Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Epidemic Cerebrospinal Meningitis Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Group A and Group C Meningococcal Polysaccharide Vaccine
5.2.2 Group A and Group C Meningococcal Conjugate Vaccine
5.2.3 Group ACYW135 Meningococcal Polysaccharide Vaccine
5.2.4 Group ACYW135 Meningococcal Conjugate Vaccine
5.2.5 Group A Meningococcal Polysaccharide Vaccine
5.2.6 Mmeningococcal Group B Vaccine
5.3 Market Segment by Type
5.3.1 World Epidemic Cerebrospinal Meningitis Vaccines Production by Type (2018-2029)
5.3.2 World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type (2018-2029)
5.3.3 World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Epidemic Cerebrospinal Meningitis Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Under 1 Year Old
6.2.2 1 Year Old and Above
6.3 Market Segment by Application
6.3.1 World Epidemic Cerebrospinal Meningitis Vaccines Production by Application (2018-2029)
6.3.2 World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application (2018-2029)
6.3.3 World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.1.4 Pfizer Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Details
7.2.2 Sanofi Pasteur Major Business
7.2.3 Sanofi Pasteur Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.2.4 Sanofi Pasteur Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Pasteur Recent Developments/Updates
7.2.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.3.4 GSK Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Hulan Bio
7.4.1 Hulan Bio Details
7.4.2 Hulan Bio Major Business
7.4.3 Hulan Bio Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.4.4 Hulan Bio Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Hulan Bio Recent Developments/Updates
7.4.6 Hulan Bio Competitive Strengths & Weaknesses
7.5 Lanzhou Institute of Biological Products
7.5.1 Lanzhou Institute of Biological Products Details
7.5.2 Lanzhou Institute of Biological Products Major Business
7.5.3 Lanzhou Institute of Biological Products Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.5.4 Lanzhou Institute of Biological Products Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lanzhou Institute of Biological Products Recent Developments/Updates
7.5.6 Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
7.6 Tianyuan biology
7.6.1 Tianyuan biology Details
7.6.2 Tianyuan biology Major Business
7.6.3 Tianyuan biology Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.6.4 Tianyuan biology Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Tianyuan biology Recent Developments/Updates
7.6.6 Tianyuan biology Competitive Strengths & Weaknesses
7.7 Walvax
7.7.1 Walvax Details
7.7.2 Walvax Major Business
7.7.3 Walvax Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.7.4 Walvax Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Walvax Recent Developments/Updates
7.7.6 Walvax Competitive Strengths & Weaknesses
7.8 Zhifei
7.8.1 Zhifei Details
7.8.2 Zhifei Major Business
7.8.3 Zhifei Epidemic Cerebrospinal Meningitis Vaccines Product and Services
7.8.4 Zhifei Epidemic Cerebrospinal Meningitis Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Zhifei Recent Developments/Updates
7.8.6 Zhifei Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Epidemic Cerebrospinal Meningitis Vaccines Industry Chain
8.2 Epidemic Cerebrospinal Meningitis Vaccines Upstream Analysis
8.2.1 Epidemic Cerebrospinal Meningitis Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Epidemic Cerebrospinal Meningitis Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Epidemic Cerebrospinal Meningitis Vaccines Production Mode
8.6 Epidemic Cerebrospinal Meningitis Vaccines Procurement Model
8.7 Epidemic Cerebrospinal Meningitis Vaccines Industry Sales Model and Sales Channels
8.7.1 Epidemic Cerebrospinal Meningitis Vaccines Sales Model
8.7.2 Epidemic Cerebrospinal Meningitis Vaccines Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Region (2018-2023) & (USD Million)
Table 3. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Region (2024-2029) & (USD Million)
Table 4. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Region (2018-2023)
Table 5. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Region (2024-2029)
Table 6. World Epidemic Cerebrospinal Meningitis Vaccines Production by Region (2018-2023) & (K Units)
Table 7. World Epidemic Cerebrospinal Meningitis Vaccines Production by Region (2024-2029) & (K Units)
Table 8. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Region (2018-2023)
Table 9. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Region (2024-2029)
Table 10. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Epidemic Cerebrospinal Meningitis Vaccines Major Market Trends
Table 13. World Epidemic Cerebrospinal Meningitis Vaccines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Epidemic Cerebrospinal Meningitis Vaccines Consumption by Region (2018-2023) & (K Units)
Table 15. World Epidemic Cerebrospinal Meningitis Vaccines Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Epidemic Cerebrospinal Meningitis Vaccines Producers in 2022
Table 18. World Epidemic Cerebrospinal Meningitis Vaccines Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Epidemic Cerebrospinal Meningitis Vaccines Producers in 2022
Table 20. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Epidemic Cerebrospinal Meningitis Vaccines Company Evaluation Quadrant
Table 22. World Epidemic Cerebrospinal Meningitis Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Epidemic Cerebrospinal Meningitis Vaccines Production Site of Key Manufacturer
Table 24. Epidemic Cerebrospinal Meningitis Vaccines Market: Company Product Type Footprint
Table 25. Epidemic Cerebrospinal Meningitis Vaccines Market: Company Product Application Footprint
Table 26. Epidemic Cerebrospinal Meningitis Vaccines Competitive Factors
Table 27. Epidemic Cerebrospinal Meningitis Vaccines New Entrant and Capacity Expansion Plans
Table 28. Epidemic Cerebrospinal Meningitis Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Epidemic Cerebrospinal Meningitis Vaccines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Epidemic Cerebrospinal Meningitis Vaccines Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Epidemic Cerebrospinal Meningitis Vaccines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share (2018-2023)
Table 37. China Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share (2018-2023)
Table 42. Rest of World Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share (2018-2023)
Table 47. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Epidemic Cerebrospinal Meningitis Vaccines Production by Type (2018-2023) & (K Units)
Table 49. World Epidemic Cerebrospinal Meningitis Vaccines Production by Type (2024-2029) & (K Units)
Table 50. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type (2018-2023) & (USD Million)
Table 51. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type (2024-2029) & (USD Million)
Table 52. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Epidemic Cerebrospinal Meningitis Vaccines Production by Application (2018-2023) & (K Units)
Table 56. World Epidemic Cerebrospinal Meningitis Vaccines Production by Application (2024-2029) & (K Units)
Table 57. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application (2018-2023) & (USD Million)
Table 58. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application (2024-2029) & (USD Million)
Table 59. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 64. Pfizer Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Pasteur Major Business
Table 69. Sanofi Pasteur Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 70. Sanofi Pasteur Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Pasteur Recent Developments/Updates
Table 72. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 76. GSK Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 80. Hulan Bio Major Business
Table 81. Hulan Bio Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 82. Hulan Bio Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hulan Bio Recent Developments/Updates
Table 84. Hulan Bio Competitive Strengths & Weaknesses
Table 85. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 86. Lanzhou Institute of Biological Products Major Business
Table 87. Lanzhou Institute of Biological Products Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 88. Lanzhou Institute of Biological Products Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 90. Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
Table 91. Tianyuan biology Basic Information, Manufacturing Base and Competitors
Table 92. Tianyuan biology Major Business
Table 93. Tianyuan biology Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 94. Tianyuan biology Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Tianyuan biology Recent Developments/Updates
Table 96. Tianyuan biology Competitive Strengths & Weaknesses
Table 97. Walvax Basic Information, Manufacturing Base and Competitors
Table 98. Walvax Major Business
Table 99. Walvax Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 100. Walvax Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Walvax Recent Developments/Updates
Table 102. Zhifei Basic Information, Manufacturing Base and Competitors
Table 103. Zhifei Major Business
Table 104. Zhifei Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 105. Zhifei Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Epidemic Cerebrospinal Meningitis Vaccines Upstream (Raw Materials)
Table 107. Epidemic Cerebrospinal Meningitis Vaccines Typical Customers
Table 108. Epidemic Cerebrospinal Meningitis Vaccines Typical Distributors
Table 1. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Region (2018-2023) & (USD Million)
Table 3. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Region (2024-2029) & (USD Million)
Table 4. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Region (2018-2023)
Table 5. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Region (2024-2029)
Table 6. World Epidemic Cerebrospinal Meningitis Vaccines Production by Region (2018-2023) & (K Units)
Table 7. World Epidemic Cerebrospinal Meningitis Vaccines Production by Region (2024-2029) & (K Units)
Table 8. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Region (2018-2023)
Table 9. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Region (2024-2029)
Table 10. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Epidemic Cerebrospinal Meningitis Vaccines Major Market Trends
Table 13. World Epidemic Cerebrospinal Meningitis Vaccines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Epidemic Cerebrospinal Meningitis Vaccines Consumption by Region (2018-2023) & (K Units)
Table 15. World Epidemic Cerebrospinal Meningitis Vaccines Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Epidemic Cerebrospinal Meningitis Vaccines Producers in 2022
Table 18. World Epidemic Cerebrospinal Meningitis Vaccines Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Epidemic Cerebrospinal Meningitis Vaccines Producers in 2022
Table 20. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Epidemic Cerebrospinal Meningitis Vaccines Company Evaluation Quadrant
Table 22. World Epidemic Cerebrospinal Meningitis Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Epidemic Cerebrospinal Meningitis Vaccines Production Site of Key Manufacturer
Table 24. Epidemic Cerebrospinal Meningitis Vaccines Market: Company Product Type Footprint
Table 25. Epidemic Cerebrospinal Meningitis Vaccines Market: Company Product Application Footprint
Table 26. Epidemic Cerebrospinal Meningitis Vaccines Competitive Factors
Table 27. Epidemic Cerebrospinal Meningitis Vaccines New Entrant and Capacity Expansion Plans
Table 28. Epidemic Cerebrospinal Meningitis Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Epidemic Cerebrospinal Meningitis Vaccines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Epidemic Cerebrospinal Meningitis Vaccines Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Epidemic Cerebrospinal Meningitis Vaccines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share (2018-2023)
Table 37. China Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share (2018-2023)
Table 42. Rest of World Based Epidemic Cerebrospinal Meningitis Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share (2018-2023)
Table 47. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Epidemic Cerebrospinal Meningitis Vaccines Production by Type (2018-2023) & (K Units)
Table 49. World Epidemic Cerebrospinal Meningitis Vaccines Production by Type (2024-2029) & (K Units)
Table 50. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type (2018-2023) & (USD Million)
Table 51. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type (2024-2029) & (USD Million)
Table 52. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Epidemic Cerebrospinal Meningitis Vaccines Production by Application (2018-2023) & (K Units)
Table 56. World Epidemic Cerebrospinal Meningitis Vaccines Production by Application (2024-2029) & (K Units)
Table 57. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application (2018-2023) & (USD Million)
Table 58. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application (2024-2029) & (USD Million)
Table 59. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 64. Pfizer Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Pasteur Major Business
Table 69. Sanofi Pasteur Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 70. Sanofi Pasteur Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Pasteur Recent Developments/Updates
Table 72. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 76. GSK Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 80. Hulan Bio Major Business
Table 81. Hulan Bio Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 82. Hulan Bio Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Hulan Bio Recent Developments/Updates
Table 84. Hulan Bio Competitive Strengths & Weaknesses
Table 85. Lanzhou Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 86. Lanzhou Institute of Biological Products Major Business
Table 87. Lanzhou Institute of Biological Products Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 88. Lanzhou Institute of Biological Products Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lanzhou Institute of Biological Products Recent Developments/Updates
Table 90. Lanzhou Institute of Biological Products Competitive Strengths & Weaknesses
Table 91. Tianyuan biology Basic Information, Manufacturing Base and Competitors
Table 92. Tianyuan biology Major Business
Table 93. Tianyuan biology Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 94. Tianyuan biology Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Tianyuan biology Recent Developments/Updates
Table 96. Tianyuan biology Competitive Strengths & Weaknesses
Table 97. Walvax Basic Information, Manufacturing Base and Competitors
Table 98. Walvax Major Business
Table 99. Walvax Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 100. Walvax Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Walvax Recent Developments/Updates
Table 102. Zhifei Basic Information, Manufacturing Base and Competitors
Table 103. Zhifei Major Business
Table 104. Zhifei Epidemic Cerebrospinal Meningitis Vaccines Product and Services
Table 105. Zhifei Epidemic Cerebrospinal Meningitis Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of Epidemic Cerebrospinal Meningitis Vaccines Upstream (Raw Materials)
Table 107. Epidemic Cerebrospinal Meningitis Vaccines Typical Customers
Table 108. Epidemic Cerebrospinal Meningitis Vaccines Typical Distributors
LIST OF FIGURES
Figure 1. Epidemic Cerebrospinal Meningitis Vaccines Picture
Figure 2. World Epidemic Cerebrospinal Meningitis Vaccines Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Epidemic Cerebrospinal Meningitis Vaccines Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 5. World Epidemic Cerebrospinal Meningitis Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 6. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Region (2018-2029)
Figure 7. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Region (2018-2029)
Figure 8. North America Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 9. Europe Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 10. China Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 11. Japan Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 12. Epidemic Cerebrospinal Meningitis Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 15. World Epidemic Cerebrospinal Meningitis Vaccines Consumption Market Share by Region (2018-2029)
Figure 16. United States Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 17. China Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 18. Europe Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 19. Japan Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 20. South Korea Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 22. India Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Epidemic Cerebrospinal Meningitis Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Epidemic Cerebrospinal Meningitis Vaccines Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Epidemic Cerebrospinal Meningitis Vaccines Markets in 2022
Figure 26. United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share 2022
Figure 30. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share 2022
Figure 32. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Type in 2022
Figure 34. Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 35. Group A and Group C Meningococcal Conjugate Vaccine
Figure 36. Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 37. Group ACYW135 Meningococcal Conjugate Vaccine
Figure 38. Group A Meningococcal Polysaccharide Vaccine
Figure 39. Mmeningococcal Group B Vaccine
Figure 40. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Type (2018-2029)
Figure 41. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Type (2018-2029)
Figure 42. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Application in 2022
Figure 45. Under 1 Year Old
Figure 46. 1 Year Old and Above
Figure 47. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Application (2018-2029)
Figure 48. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Application (2018-2029)
Figure 49. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Epidemic Cerebrospinal Meningitis Vaccines Industry Chain
Figure 51. Epidemic Cerebrospinal Meningitis Vaccines Procurement Model
Figure 52. Epidemic Cerebrospinal Meningitis Vaccines Sales Model
Figure 53. Epidemic Cerebrospinal Meningitis Vaccines Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Epidemic Cerebrospinal Meningitis Vaccines Picture
Figure 2. World Epidemic Cerebrospinal Meningitis Vaccines Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Epidemic Cerebrospinal Meningitis Vaccines Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 5. World Epidemic Cerebrospinal Meningitis Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 6. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Region (2018-2029)
Figure 7. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Region (2018-2029)
Figure 8. North America Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 9. Europe Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 10. China Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 11. Japan Epidemic Cerebrospinal Meningitis Vaccines Production (2018-2029) & (K Units)
Figure 12. Epidemic Cerebrospinal Meningitis Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 15. World Epidemic Cerebrospinal Meningitis Vaccines Consumption Market Share by Region (2018-2029)
Figure 16. United States Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 17. China Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 18. Europe Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 19. Japan Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 20. South Korea Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 22. India Epidemic Cerebrospinal Meningitis Vaccines Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Epidemic Cerebrospinal Meningitis Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Epidemic Cerebrospinal Meningitis Vaccines Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Epidemic Cerebrospinal Meningitis Vaccines Markets in 2022
Figure 26. United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Epidemic Cerebrospinal Meningitis Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share 2022
Figure 30. China Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Epidemic Cerebrospinal Meningitis Vaccines Production Market Share 2022
Figure 32. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Type in 2022
Figure 34. Group A and Group C Meningococcal Polysaccharide Vaccine
Figure 35. Group A and Group C Meningococcal Conjugate Vaccine
Figure 36. Group ACYW135 Meningococcal Polysaccharide Vaccine
Figure 37. Group ACYW135 Meningococcal Conjugate Vaccine
Figure 38. Group A Meningococcal Polysaccharide Vaccine
Figure 39. Mmeningococcal Group B Vaccine
Figure 40. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Type (2018-2029)
Figure 41. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Type (2018-2029)
Figure 42. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Epidemic Cerebrospinal Meningitis Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Application in 2022
Figure 45. Under 1 Year Old
Figure 46. 1 Year Old and Above
Figure 47. World Epidemic Cerebrospinal Meningitis Vaccines Production Market Share by Application (2018-2029)
Figure 48. World Epidemic Cerebrospinal Meningitis Vaccines Production Value Market Share by Application (2018-2029)
Figure 49. World Epidemic Cerebrospinal Meningitis Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Epidemic Cerebrospinal Meningitis Vaccines Industry Chain
Figure 51. Epidemic Cerebrospinal Meningitis Vaccines Procurement Model
Figure 52. Epidemic Cerebrospinal Meningitis Vaccines Sales Model
Figure 53. Epidemic Cerebrospinal Meningitis Vaccines Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
